Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteins. | Mol Endocrinol;12(8): 1120-32, 1998 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteins.

Logie, C; Nichols, M; Myles, K; Funder, J W; Stewart, A F.

Affiliation

Logie C; Gene Expression Program, European Molecular Biology Laboratory, Heidelberg, Germany.

Mol Endocrinol ; 12(8): 1120-32, 1998 Aug.

Article in En | MEDLINE | ID: mdl-9717838

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Receptors, Estrogen / DNA Nucleotidyltransferases / Estrogen Antagonists Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Endocrinol Journal subject: BIOLOGIA MOLECULAR / ENDOCRINOLOGIA Year: 1998 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Receptors, Estrogen / DNA Nucleotidyltransferases / Estrogen Antagonists Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Endocrinol Journal subject: BIOLOGIA MOLECULAR / ENDOCRINOLOGIA Year: 1998 Document type: Article Affiliation country: Country of publication: